Epidemiology Controls Using Healthy Participants

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

1500 participants

Study Classification

OBSERVATIONAL

Study Start Date

2004-06-30

Study Completion Date

2019-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this research study is to identify biologic and lifestyle factors that may increase a person's risk of developing certain types of cancer.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Counting Steps! Integration of Objectively Assessed Physical Activity and Fitness With Smartphones in Clinical Oncology Practice.

NCT03493672

Neoplasms

COMPLETED

Routine Evaluation of the Social Determinants of Health in Oncology: User-centered Resource Coordination and Engagement

NCT04879927

Breast Cancer Lung Cancer Gastrointestinal Cancer

COMPLETED NA

The Active After Cancer Trial (AACT)

NCT00548236

Breast Cancer Colorectal Cancer

ACTIVE_NOT_RECRUITING NA

Home-based Exercise Intervention for Patients With Metastatic Prostate Cancer

NCT03672396

Castration-resistant Prostate Cancer Androgen Deprivation Therapy

COMPLETED NA

Interactive Cancer Communication System (ICCS) Directed Physical Activity Enhancement for Colon Cancer Survivors

NCT01133132

Colon Cancer

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

For this study, you will be asked to complete a personal interview. During the interview, you will be asked questions about your demographics (age, sex, etc.), certain environmental exposures, your medical history, family history, your diet, and your smoking and alcohol use histories. It should take around 50 minutes to complete the interview.

You will also have around 2 ½ tablespoons of blood drawn for special tests. These tests will look for any biologic factors associated with certain cancers. The interview and blood draw will be scheduled at the time and place of your convenience. You will not be informed of the results of any of the testing done with your samples.

There is a possibility that you might be contacted in the future about if researchers need clarification on any of information already collected. You are free to refuse any further participation if you wish.

This is an investigational study. Up to 1,500 participants will take part in this study.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Healthy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Control

Person with no history of cancer.

Questionnaire

Intervention Type BEHAVIORAL

50 Minute Interview

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Questionnaire

50 Minute Interview

Intervention Type BEHAVIORAL

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Survey

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Individuals ages 18 and over with no prior cancer
2. Willing and able to complete an administered questionnaire
3. Willing and able to donate 30 mL of blood